Did you know that your browser is out of date?
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
As risk management has become a critical part of strategic planning, businesses are recognizing the need to evaluating the “risk landscape” of their firm in the aggregate, rather than just measuring and managing individual risks one at a time. With extensive professional experience in risk analysis and risk management techniques, NERA's Financial Risk Management experts are well versed in modeling, analyzing, and communicating the effects of combined risks to financial and non-financial institutions. Our experts assist clients in measuring individual risk exposures and aggregating these risks across risk factors and business units, taking into account correlations and diversification effects, to measure their combined effect on performance measures such as earnings-at-risk or cash-flow-at-risk. Clients benefit by having an improved quantification of the risks they face, a better assessment of the impact of their risk transfer activities -- hedging and insurance -- on their overall risk, more precise contingency planning, and more accurate budgeting and financial planning.
NERA experts are recognized as thought leaders in the field of risk management, and have a distinct ability to evaluate the trends that are likely to represent the best practices of tomorrow. NERA's experts have assisted various industry bodies, such as the Group of Thirty, the International Swaps and Derivatives Association, and the Treasury Management Association, in developing risk management principles and evaluating best practices.
Name | Title | Location | Phone | |
---|---|---|---|---|
Lucy P. Allen | Managing Director | New York City | +1 212 345 5913 | lucy.allen@nera.com |
Dr. Denise Neumann Martin | Managing Director | Miami | +1 212 345 5296 | denise.martin@nera.com |
Dr. Faten Sabry |
Managing Director
Chair of NERA's Global Securities and Finance Practice Bankruptcy Practice Chair |
New York City
London |
+1 212 345 3285
+44 20 7659 8618 |
faten.sabry@nera.com |
Adam Warren | Managing Director | Chicago | +1 (312) 573-2821 | adam.warren@nera.com |
Dr. Ling Ling Ang | Associate Director |
New York City
Washington, DC Chicago |
+1 212 345 5409
+1 202 466 9259 +312 573 2827 |
lingling.ang@nera.com |
Dr. Airat Chanyshev | Associate Director | New York City | +1 212 345 7336 | airat.chanyshev@nera.com |
Drew Claxton | Associate Director | New York City | +1 212 345 3442 | drew.claxton@nera.com |
Erin B. McHugh | Associate Director |
London
New York City |
+44 20 7659 8736
+1 212 345 2990 |
erin.mchugh@nera.com |
Dr. Jordan Milev | Associate Director | New York City | +1 212 345 5516 | jordan.milev@nera.com |
Dr. James Overdahl | Affiliated Industry Expert | Washington, DC | +1 202 547 3035 | joverdahl@deltastrat.com |
Dr. Andrew Carron | Affiliated Consultant |
New York City
London |
+1 212 345 5407
+44 20 7659 8500 |
andrew.carron.affiliate@nera.com |
Dr. James Jordan | Affiliated Consultant | Washington, DC | +1 202 466 9263 | james.jordan.affiliate@nera.com |